GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (STU:5YI) » Definitions » Short Interest

Nyxoah (STU:5YI) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Nyxoah's Short Interest

For the Medical Instruments & Supplies subindustry, Nyxoah's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nyxoah's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Short Interest distribution charts can be found below:

* The bar in red indicates where Nyxoah's Short Interest falls into.


Nyxoah (STU:5YI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (STU:5YI) » Definitions » Short Interest
Comparable Companies
XTAE:ORBI XTAE:FBRT XTAE:BSEN XTAE:TATT XTAE:ISI ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX XPAR:DIM HOLX TSE:7733 COO
Traded in Other Exchanges
NYXH:USA NYXH:Belgium
Address
Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Website
https://www.nyxoah.com
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Nyxoah (STU:5YI) Headlines

No Headlines